Capital Analysts, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1624758
FORT WASHINGTON, PA
Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$405,301
+$3,529 QoQ
Shares Held
650
+25.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#859
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Analysts, LLC holds $605,272 across 14 Biotechnology names. REGN ranks #1 (67.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
650 | $405,301 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
119 | $59,110 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
2,661 | $46,301 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
446 | $25,520 | |
| 5 | MRNA |
Moderna, Inc.
|
163 | $11,414 | |
| 6 | SPRY |
ARS Pharmaceuticals, Inc.
|
1,300 | $10,413 | |
| 7 | OMER |
Omeros Corp
|
1,000 | $9,510 | |
| 8 | VRCA |
Verrica Pharmaceuticals Inc.
|
1,500 | $9,180 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $405,301 | 650 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $401,772 | 520 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $402,916 | 522 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $340,173 | 605 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $216,825 | 413 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $261,936 | 413 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $282,795 | 397 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $344,806 | 328 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $352,095 | 335 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $283,934 | 295 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $258,217 | 294 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $242,773 | 295 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $203,346 | 283 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $239,105 | 291 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $226,547 | 314 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $236,282 | 343 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $223,447 | 378 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $255,621 | 366 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $292,393 | 463 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $269,910 | 446 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $223,416 | 400 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $190,202 | 402 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $181,166 | 375 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $456,220 | 815 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $271,287 | 435 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $239,262 | 490 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||